physicians using TAVR
TAVR Clinical Trial Provides ‘Strong Signal’ Procedure is Safe for Patients with Low Surgical Mortality Risk
Patients Undergoing Transcatheter Aortic Valve Replacement Showed No Deaths or Disabling Strokes within 30 days of Undergoing Less Invasive Procedure



Tags : aortic stenosis , Low-Risk TAVR trial , MedStar Heart & Vascular Institute , TAVR ,

Category : Cardiology , Vascular ,